Milestone Pharmaceuticals Inc (NASDAQ: MIST): Do Not Miss The Gain Train

Milestone Pharmaceuticals Inc (MIST) concluded trading on Thursday at a closing price of $1.79, with 0.45 million shares of worth about $0.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.31% during that period and on March 28, 2024 the price saw a loss of about -0.56%. Currently the company’s common shares owned by public are about 53.15M shares, out of which, 50.45M shares are available for trading.

Stock saw a price change of 14.74% in past 5 days and over the past one month there was a price change of -15.96%. Year-to-date (YTD), MIST shares are showing a performance of 7.19% which decreased to -55.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.33 but also hit the highest price of $4.49 during that period. The average intraday trading volume for Milestone Pharmaceuticals Inc shares is 377.81K. The stock is currently trading 14.36% above its 20-day simple moving average (SMA20), while that difference is up 11.42% for SMA50 and it goes to -29.92% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Milestone Pharmaceuticals Inc (NASDAQ: MIST) currently have 53.15M outstanding shares and institutions hold larger chunk of about 31.51% of that.

The stock has a current market capitalization of $95.14M and its 3Y-monthly beta is at 1.77. It has posted earnings per share of -$1.48 in the same period. It has Quick Ratio of 10.11 while making debt-to-equity ratio of 3.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MIST, volatility over the week remained 11.14% while standing at 10.38% over the month.

Analysts are in expectations that Milestone Pharmaceuticals Inc (MIST) stock would likely to be making an EPS of -$0.26 in the current quarter, while forecast for next quarter EPS is -$0.26 and it is -$1.54 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.31 which is -$0.21 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.35 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 17.27% while it is estimated to decrease by -34.35% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on June 20, 2023 offering a Hold rating for the stock and assigned a target price range of between $8 and $4 to it. Coverage by Piper Sandler stated Milestone Pharmaceuticals Inc (MIST) stock as an Overweight in their note to investors on April 22, 2022, suggesting a price target of $10 for the stock. On March 05, 2021, H.C. Wainwright Initiated their recommendations, while on July 29, 2020, Oppenheimer Upgrade their ratings for the stock with a price target of $18. Stock get a Buy rating from Jefferies on July 24, 2020.

Most Popular

Related Posts